Jump to main content

yr 〜
yr

Search results 8

Activated partial thromboplastin time‑based clot waveform analysis enables measurement of very low levels of factor IX activity in patients with severe hemophilia B

Activated partial thromboplastin time‑based clot waveform analysis enables measurement of very low levels of factor IX activity in patients with severe hemophilia B
Digital博士論文障害者向け資料あり
Nishiyama, Atsuko, Ogiwara, Kenichi, Mizumachi, Kuniyoshi, Hashimoto, Naoki, Takeyama, Masahiro, Nogami, KeijiSpringer2022-11
National Diet Library
  • Subject HeadingHemophilia B Factor IX Severity Clot waveform analysis Activity
  • Note (General)...t method using clot waveform analysis (CWA).Residual FIX:C by addin...

Screening of the protein C pathway abnormality-related thrombophilia by using thrombomodulin-mediated tissue factor-triggered clot waveform analysis.

Screening of the protein C pathway abnormality-related thrombophilia by using thrombomodulin-mediated tissue factor-triggered clot waveform analysis.
Digital博士論文障害者向け資料あり
Hashimoto, Naoki, Ogiwara, Kenichi, Shimonishi, Naruto, Nakagawa, Takashi, Nakajima, Yuto, Furukawa, Shoko, Takeyama, Masahiro, Nogami, KeijiWiley2022-07
National Diet Library
  • Subject Headingclot waveform analysis factor V protein C pathway th...
  • Note (General)... one utilizing clot waveform analysis (CWA) remains unknown. We aim...

Dynamic evaluation of hemostasis in the acute phase of Kawasaki disease using comprehensive coagulation functional assays. 174

Dynamic evaluation of hemostasis in the acute phase of Kawasaki disease using comprehensive coagulation functional assays. 174
Digital博士論文障害者向け資料あり
Yoshizawa, Hiroyuki, Nogami, Keiji, Matsumoto, Tomoko, Tsujii, Nobuyuki, Sakai, Toshiyuki, Takase, Toshio, Tanaka, Ichiro, Shima, MidoriElsevier2019-02Thrombosis research
National Diet Library
  • Subject HeadingKawasaki disease Clot waveform analysis Thrombin generation Plasmin g...
  • Note (General)...lation assays, clot waveform analysis (CWA) and thrombin/plasmin ge...

Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro. 17 1

Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro. 17 1
Digital博士論文障害者向け資料あり
Minami, Hiroaki, Nogami, Keiji, Yada, Koji, Ogiwara, Kenichi, Furukawa, Shoko, Soeda, Tetsuhiro, Kitazawa, Takehisa, Shima, MidoriJohn Wiley and Sons, Inc.2019-01Journal of thrombosis and haemostasis
National Diet Library
  • Subject Headingclot waveform analysis emicizumab factor XI deficien...
  • Note (General)...of emicizumab, clot waveform analysis (CWA) in FXI-deficient plasma...

Activated partial thromboplastin time‑based clot waveform analysis enables measurement of very low levels of factor IX activity in patients with severe hemophilia B

Activated partial thromboplastin time‑based clot waveform analysis enables measurement of very low levels of factor IX activity in patients with severe hemophilia B
Digital博士論文
Nishiyama, Atsuko, Ogiwara, Kenichi, Mizumachi, Kuniyoshi, Hashimoto, Naoki, Takeyama, Masahiro, Nogami, KeijiSpringer2022-11International journal of hematology116 5p.778-786
Available onlineOther Libraries in Japan
  • Subject HeadingHemophilia B Factor IX Severity Clot waveform analysis Activity
  • Note (General)...t method using clot waveform analysis (CWA). Residual FIX:C by addi...

Screening of the protein C pathway abnormality-related thrombophilia by using thrombomodulin-mediated tissue factor-triggered clot waveform analysis.

Screening of the protein C pathway abnormality-related thrombophilia by using thrombomodulin-mediated tissue factor-triggered clot waveform analysis.
Digital博士論文
Hashimoto, Naoki, Ogiwara, Kenichi, Shimonishi, Naruto, Nakagawa, Takashi, Nakajima, Yuto, Furukawa, Shoko, Takeyama, Masahiro, Nogami, KeijiWiley2022-07European journal of haematology109 1p.100-108
Available onlineOther Libraries in Japan
  • Subject Headingclot waveform analysis factor V protein C pathway th...
  • Note (General)... one utilizing clot waveform analysis (CWA) remains unknown. We aim...

Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro.

Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro.
Digital博士論文
Minami, Hiroaki, Nogami, Keiji, Yada, Koji, Ogiwara, Kenichi, Furukawa, Shoko, Soeda, Tetsuhiro, Kitazawa, Takehisa, Shima, MidoriJohn Wiley and Sons, Inc.2019-01Journal of thrombosis and haemostasis17 1p.126-137
Available onlineOther Libraries in Japan
  • Subject Headingclot waveform analysis emicizumab factor XI deficien...
  • Note (General)...of emicizumab, clot waveform analysis (CWA) in FXI-deficient plasma...

Dynamic evaluation of hemostasis in the acute phase of Kawasaki disease using comprehensive coagulation functional assays.

Dynamic evaluation of hemostasis in the acute phase of Kawasaki disease using comprehensive coagulation functional assays.
Digital博士論文
Yoshizawa, Hiroyuki, Nogami, Keiji, Matsumoto, Tomoko, Tsujii, Nobuyuki, Sakai, Toshiyuki, Takase, Toshio, Tanaka, Ichiro, Shima, MidoriElsevier2019-02Thrombosis research174p.76-83
Available onlineOther Libraries in Japan
  • Subject HeadingKawasaki disease Clot waveform analysis Thrombin generation Plasmin g...
  • Note (General)...lation assays, clot waveform analysis (CWA) and thrombin/plasmin ge...

Reached to the end of result.

RSS